Cardiac & Interventional
Industry-leading expertise in design, development, and complex assembly.
Highly skilled in the design, development, and complex assembly of a wide range of cardiac and interventional devices. Viant’s specialized capabilities include: overmolding, and nitinol tubing. Additionally, we leverage both tubing and surgical technology expertise to manufacture precision hypotube components for cardiac and interventional applications.
- Catheters & Delivery Systems
-
Catheters & Delivery Systems
Products & services:
- Complex Interventional Devices
- Steerable, Balloon, and RF Ablation Catheters
- Closure Devices (Femoral, Arterial and Venous Access)
- Introducers for Transradial Artery Access
- Hypotubes
- Surgical
-
Surgical
Products & services:- Heart Positioners
- Aortic Punches
- Syringes
- Arterial, Femoral, and Venous Cannulae for Extracorporeal Circuits
- Heart Valve Holders
- Delivery Systems
Catheters & Delivery Systems
Products & services:
- Complex Interventional Devices
- Steerable, Balloon, and RF Ablation Catheters
- Closure Devices (Femoral, Arterial and Venous Access)
- Introducers for Transradial Artery Access
- Hypotubes
Surgical
Products & services:
- Heart Positioners
- Aortic Punches
- Syringes
- Arterial, Femoral, and Venous Cannulae for Extracorporeal Circuits
- Heart Valve Holders
- Delivery Systems
Clinical Applications
Viant covers a range of clinical markets and applications when if comes to Cardiac and Interventional, including:
Cardiac Surgery
Trancatheter Terapies
Structural Heart
Electrophysiology
Cardiac & Interventional Success Stories
See our innovation and expertise in action
Key Component for Stent Delivery System Gets Innovative Solution
A leading, multinational medical technology company was seeking a strategic partner to develop and manufacture a key component of its next-generation, catheter-based stent delivery system.
Transfer of Catheter to Low-Cost Geography Improves Manufacturing Process
CUSTOMER SITUATION Viant saw an opportunity to increase efficiencies by transferring a medical device it had been manufacturing in the US for more than a